Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Progress in stem cell-derived technologies for hepatocellular carcinoma
Rajagopal N. Aravalli
Radiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Progress in stem cell-derived technologies for hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatocellular Carcinoma
100%
Stem Cell-derived
100%
Liver Cancer
100%
Liver Transplantation
66%
Malignancy
33%
Transplantation
33%
Poor Prognosis
33%
Stem Cells
33%
Stem Cell Therapy
33%
Cirrhosis
33%
Advanced Stage
33%
Surgical Resection
33%
Mammalian Cells
33%
Liver Disease
33%
Tissue Damage
33%
Alternative Therapy
33%
Primary Hepatocellular Carcinoma
33%
Immune Rejection
33%
Immune Tissue
33%
Donor Risk
33%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Stem Cell
100%
Liver Cancer
100%
Liver Transplantation
66%
Cancer
33%
Stem Cell Therapy
33%
Hope
33%
Liver Cirrhosis
33%
Liver Disease
33%
Tissue Injury
33%
Mammalian Cell
33%